All 23andMe articles
-
Business
Pharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
Business
US opens up home DNA screening
FDA approves single disease genetic test and clears pathway for similar devices
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits